Wells Fargo raised the firm’s price target on McKesson (MCK) to $914 from $816 and keeps an Equal Weight rating on the shares. The firm is updating its model following Q2 2026 earnings and increasing its tests following core pharma distribution and prescription technology strength.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: